BAXALTA US INC.

Form 483 issued November 26, 2025 · Round Lake, Illinois

Inspection
Oct 27 – Nov 26, 2025
Investigators
Peng Zhou· Shafig Ahadi
Observations
1
Pages
9
FEI number
3012385969

In short: On November 26, 2025, FDA issued a Form 483 with 1 observation to BAXALTA US INC. in Round Lake, Illinois (FEI 3012385969) after an inspection that ran Oct 27 – Nov 26, 2025. The investigators were Peng Zhou and Shafig Ahadi. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.22(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not fully followed. A. Since…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at BAXALTA US INC.?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected BAXALTA US INC.?

Peng Zhou and Shafig Ahadi are named on this Form 483, for the inspection of Oct 27 – Nov 26, 2025. Each investigator has a profile showing what they cite most.

When was BAXALTA US INC. inspected by FDA?

The inspection ran Oct 27 – Nov 26, 2025, and the Form 483 is dated November 26, 2025.

How do I get the full Form 483 for BAXALTA US INC.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free